
ABUS vs ANL
$ABUS vs $ANL head to head: price, market cap, valuation, dividend, free float, relative volume and how actively each trades. The bigger value in the size rows is bolded. Tap either ticker for its live chart, full ownership breakdown and real-time alerts.
ABUS vs ANL: the quick read
- ·ANL is the larger company by market cap ($886M vs $880M).
- ·ABUS has been more active on our scanner (113 vs 29 alerts in 30 days).
- ·ANL has the smaller float (64.4M vs 142.9M), which tends to mean sharper, more volatile moves.
- ·These sit in different industries (PHARMACEUTICAL PREPARATIONS vs Pharmaceutical Preparations), so they answer to different catalysts and a move in one says little about the other.
- ·ABUS draws far more of our scanner's attention, 113 unusual-volume alerts in 30 days against 29, so it is the more actively traded of the two by some distance.
- ·They are closely matched in size, within 1% of each other on market cap, which makes the rest of this table the interesting part.
- ·ANL pays a dividend and ABUS does not, which usually means one is being held for income and the other for the move.
Objective differences only. Not investment advice.
Get the best catches in your inbox
Free daily email of the top plays and unusual-volume alerts our scanner flags. No account needed.
No spam. Unsubscribe anytime. Not investment advice.
Frequently asked questions
Everything you need to know comparing ABUS and ANL on TheDesperateTrader.
- Is ABUS or ANL the better stock?
- "Better" depends on your goal, and these two are not alike. ANL is the larger company by market cap ($886M vs $880M). ABUS has been more active on our scanner (113 vs 29 alerts in 30 days). ANL has the smaller float (64.4M vs 142.9M), which tends to mean sharper, more volatile moves. Those are the measured differences, not a recommendation, and nothing here is investment advice.
- What is the difference between ABUS and ANL?
- The differences that matter: they are not in the same business - ABUS is pharmaceutical preparations and ANL is pharmaceutical preparations; they are similar in size ($880M vs $886M); they trade at very different share prices ($4.58 vs $15.31); ABUS sits at 55% of its 52-week range against 88% for ANL; only ANL pays a dividend; our scanner flagged ABUS 113 times in the last 30 days against 29 for ANL. Everything above is measured from the latest completed session and SEC filings.
- Which of ABUS and ANL is more active right now?
- Right now ABUS is at about 1.2x its normal volume and ANL is at about 0.5x, so ABUS is the one drawing unusual attention today. Relative volume (RVOL) compares a stock's volume to its own recent average, so it reads the same way for a megacap and a microcap and is the quickest way to tell which of two similar names is actually in play.
- Is this comparison data live?
- Prices and % changes are anchored to the latest completed session and split-adjusted, so a reverse split never shows as a fake move. Float is estimated from SEC filings and refreshed as new filings publish.
Trading ABUS or ANL? Get real-time unusual-volume alerts the moment either one moves, free.
No card · 5 premium daysMore ABUS and ANL comparisons
Same sector, similar size. These are the peers each one is usually weighed against.
Explore the market
Free, live market tools. No account required to look.